PET Imaging in the Management of Neuroendocrine Tumors, An Issue of PET Clinics, 1st Edition

Author :
By Stefano Fanti, Cristina Nanni, MD and Richard P. Baum, MD
Nuclear Medicine has greatly contributed to the diagnosis and treament of neuroendocrine neoplasms. This issue of PET Clinics will focus not only on the diagnosis and treatment of neuroendocrine tumors, but also theranostics. Topics include SPECT and ...view more
Nuclear Medicine has greatly contributed to the diagnosis and treament of neuroendocrine neoplasms. This issue of PET Clinics will focus not only on the diagnosis and treatment of neuroendocrine tumors, but also theranostics. Topics include SPECT and other PET tracers, F-DOPA, Ga-DOTA-peptides, Yttrium- and Lutetium-based therapy, and the role of FDG PET. It also covers key information of theranostics.
ISBN :
9780323264044
Publication Date :
02-12-2013
Stock Status :
Please allow 7-10 working days for delivery
Earn 10 Points
Add to Cart
Nuclear Medicine has greatly contributed to the diagnosis and treament of neuroendocrine neoplasms. This issue of PET Clinics will focus not only on the diagnosis and treatment of neuroendocrine tumors, but also theranostics. Topics include SPECT and other PET tracers, F-DOPA, Ga-DOTA-peptides, Yttrium- and Lutetium-based therapy, and the role of FDG PET. It also covers key information of theranostics.

Author Information
By Stefano Fanti, Intitute of Nuclear Medicine, University of Bologna, Italy; Cristina Nanni, MD, Nuclear Medicine Department, Intitute of Nuclear Medicine, University of Bologna, Italy and Richard P. Baum, MD, Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Germany